Find Your Next Partner — and the Next Wave of Asian Innovation
BioCentury, BayHelix, and Insights Partner McKinsey & Company return to continue the debate on Asia's Arc of Innovation — bringing together the leaders shaping the next chapter of global biopharma.
As Asian biotechs race to globalize — through licensing deals, NewCo formation, and cross-border partnerships — the stakes have never been higher. Where will the next wave of innovation emerge? Who are the new power brokers connecting East and West?
Join us for C-level networking, partnering, and debate, tailored for VCs, CEOs, CFOs, CBOs, and decision-makers driving biopharma innovation across Asia and the West.